Tolerability and Toxicity of Trastuzumab or Trastuzumab + Lapatinib in Older Patients: A Sub-analysis of the ALTTO Trial (BIG 2–06; NCCTG (Alliance) N063D)
- Citation:
- Breast Cancer Res Treat vol 185 (1) 107-116
- Year:
- 2021
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- Received
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 3088
- Children:
- None
- Pharmas:
- GSK, Novartis
- Grants:
- U10CA180821, UG1CA233180, UG1CA232760
- Corr. Author:
- Authors:
- Noam Pondé Dominique Agbor-Tarh Lissandra Dal Lago Larissa A. Korde Florentine Hilbers Christian Jackisch Olena Werner Richard D. Gelber Aminah Jatoi Amylou C. Dueck Alvaro Moreno-Aspitia Christos Sotiriou Evandro de Azambuja Martine Piccart
- Networks:
- LAPS-MN026
- Study
- NCCTG-N063D
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- breast cancer, geriatric oncology, anti-HER2